The Mini Alcohol Craving Experience Questionnaire: Development and Clinical Application
dc.contributor.author | Coates, JM | |
dc.contributor.author | Gullo, MJ | |
dc.contributor.author | Feeney, GFX | |
dc.contributor.author | Kavanagh, DJ | |
dc.contributor.author | Young, RM | |
dc.contributor.author | Dingle, GA | |
dc.contributor.author | May, Jon | |
dc.contributor.author | Andrade, Jackie | |
dc.contributor.author | Statham, DJ | |
dc.contributor.author | Connor, JP | |
dc.date.accessioned | 2017-01-10T11:11:15Z | |
dc.date.available | 2017-01-10T11:11:15Z | |
dc.date.issued | 2016-12 | |
dc.identifier.issn | 0145-6008 | |
dc.identifier.issn | 1530-0277 | |
dc.identifier.uri | http://hdl.handle.net/10026.1/8226 | |
dc.description.abstract |
<jats:sec><jats:title>Background</jats:title><jats:p>Standardized alcohol craving scales are rarely used outside of research environments despite recognized clinical utility. Scale length is a key barrier to more widespread application. A brief measure of alcohol craving is needed to improve research and treatment of alcohol use disorders (<jats:styled-content style="fixed-case">AUD</jats:styled-content>s). Grounded in the Elaborated Intrusion Theory of Desire, the Alcohol Craving Experience (<jats:styled-content style="fixed-case">ACE</jats:styled-content>) Questionnaire comprises two 11‐item self‐report scales that assess past‐week frequency and maximum strength of alcohol craving. This study aimed to create a brief version of the <jats:styled-content style="fixed-case">ACE</jats:styled-content> while maintaining psychometric integrity and clinical utility.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Patients attending a university hospital alcohol and drug outpatient service for the treatment of <jats:styled-content style="fixed-case">AUD</jats:styled-content> completed the <jats:styled-content style="fixed-case">ACE</jats:styled-content> as part of a questionnaire battery. Three patient samples were utilized: 519 patients with pretreatment and outcome data, 228 patients with pretreatment data, and 66 patients who completed the <jats:styled-content style="fixed-case">ACE</jats:styled-content> at treatment sessions 1 and 2.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The Frequency scale of the <jats:styled-content style="fixed-case">ACE</jats:styled-content> possessed greater clinical utility and predictive validity than the Strength scale. Revision of the Frequency measure produced a 5‐item “Mini Alcohol Craving Experience” (<jats:styled-content style="fixed-case">MACE</jats:styled-content>) Questionnaire. Satisfactory validity (construct, predictive, concurrent, convergent, and incremental) and reliability (internal and test–retest) were maintained. A 1 standard deviation increase in pretreatment <jats:styled-content style="fixed-case">MACE</jats:styled-content> score was associated with a 54 percentage increase in the odds of patient lapse or dropout.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>The <jats:styled-content style="fixed-case">MACE</jats:styled-content> provides a brief, theoretically, and psychometrically robust measure of alcohol craving suitable for use with <jats:styled-content style="fixed-case">AUD</jats:styled-content> populations in time‐limited clinical and research settings.</jats:p></jats:sec> | |
dc.format.extent | 156-164 | |
dc.format.medium | Print-Electronic | |
dc.language | en | |
dc.language.iso | en | |
dc.publisher | Wiley | |
dc.subject | Alcohol Use Disorder | |
dc.subject | Craving | |
dc.subject | Urge | |
dc.subject | Measurement | |
dc.subject | Scale Development | |
dc.title | The Mini Alcohol Craving Experience Questionnaire: Development and Clinical Application | |
dc.type | journal-article | |
dc.type | Journal Article | |
plymouth.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000393890700017&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008 | |
plymouth.issue | 1 | |
plymouth.volume | 41 | |
plymouth.publication-status | Published | |
plymouth.journal | Alcoholism: Clinical and Experimental Research | |
dc.identifier.doi | 10.1111/acer.13278 | |
plymouth.organisational-group | /Plymouth | |
plymouth.organisational-group | /Plymouth/Admin Group - REF | |
plymouth.organisational-group | /Plymouth/Admin Group - REF/REF Admin Group - FoH | |
plymouth.organisational-group | /Plymouth/Faculty of Health | |
plymouth.organisational-group | /Plymouth/Faculty of Health/School of Psychology | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA/UoA04 Psychology, Psychiatry and Neuroscience | |
plymouth.organisational-group | /Plymouth/REF 2021 Researchers by UoA/UoA04 Psychology, Psychiatry and Neuroscience/UoA04 REF peer reviewers | |
plymouth.organisational-group | /Plymouth/Research Groups | |
plymouth.organisational-group | /Plymouth/Research Groups/Centre for Brain, Cognition and Behaviour (CBCB) | |
plymouth.organisational-group | /Plymouth/Research Groups/Centre for Brain, Cognition and Behaviour (CBCB)/Behaviour | |
plymouth.organisational-group | /Plymouth/Research Groups/Centre for Brain, Cognition and Behaviour (CBCB)/Cognition | |
plymouth.organisational-group | /Plymouth/Research Groups/Institute of Health and Community | |
plymouth.organisational-group | /Plymouth/Research Groups/Plymouth Institute of Health and Care Research (PIHR) | |
plymouth.organisational-group | /Plymouth/Users by role | |
plymouth.organisational-group | /Plymouth/Users by role/Academics | |
dc.publisher.place | England | |
dcterms.dateAccepted | 2016-10-24 | |
dc.rights.embargodate | 2017-12-26 | |
dc.identifier.eissn | 1530-0277 | |
dc.rights.embargoperiod | Not known | |
rioxxterms.versionofrecord | 10.1111/acer.13278 | |
rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.licenseref.startdate | 2016-12 | |
rioxxterms.type | Journal Article/Review |